Mumbai,
Aug 24: Pharma Firm, Alembic Pharmaceuticals (Alembic Pharma) has sold its
formulations manufacturing facility at Baddi to Scott Edil Pharmacia (SEPL),
the company said in a filing to the bourses on Wednesday . SEPL does not belong
to the promoter or promoter group or group companies and is not related party
of the company. The turnover and networth of the said manufacturing facility
for the last financial year vis-à-vis turnover and networth of the company is
insignificant, the company added. The company continues to meet its domestic
formulation demand from Sikkim Unit and international formulation demand from
its Panelav Unit. Alembic Pharmaceuticals is engaged developing formulations
and active pharmaceutical ingredients (API). The company focuses on
anti-infective, analgesic and cough and cold therapies. It also focuses on
therapies, such as cardiology, diabetes, gynaecology, gastrointestinal,
orthopedic, dermatology and ophthalmology. UNI
Post A Comment:
0 comments so far,add yours